CI has filed to sell common stock under Rule 144. The filing lists 19,436 shares of common stock to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $5,369,583.72. Shares outstanding are reported as 264,240,486.
The shares derive from prior restricted stock vesting events in 2015, 2016, 2024, 2025 and 2026, and stock option exercises in 2019 and 2026, received as compensation or for cash.
The Cigna Group reported Q2 2026 results with total revenues of $71,668 million, up from $67,178 million a year earlier, driven mainly by higher Evernorth Health Services pharmacy revenues. Shareholders' net income was $1,660 million, and diluted EPS was $6.29, both above Q2 2025.
For the first half of 2026, revenues reached $140,162 million and shareholders' net income $3,314 million. As of June 30, 2026, the company reported $157,082 million in total assets and $42,620 million of shareholders' equity, including $6,298 million of cash and cash equivalents.
Net cash provided by operating activities was $710 million for the first six months, while the company repaid $550 million of maturing senior notes, maintained a $6,500 million undrawn revolving credit facility, and had $1,000 million of commercial paper outstanding. Cigna incurred $450 million of year-to-date strategic optimization program costs and continued returning capital through dividends and common share repurchases.
The Cigna Group reported higher revenue and net income for the three months ended June 30, 2026. Total revenues were $71,668 million, up from $67,178 million a year earlier. Shareholders’ net income was $1,660 million, or $6.29 per share, compared with $1,532 million, or $5.71 per share.
Adjusted income from operations was $2,054 million, or $7.78 per share, versus $1,930 million, or $7.20, in second quarter 2025. Evernorth Health Services generated adjusted revenues of $61,468 million and pre-tax adjusted income of $1,663 million, while Cigna Healthcare delivered adjusted revenues of $11,728 million and pre-tax adjusted income of $1,276 million. In April 2026, the company announced a planned exit from the Individual and Family Plans medical business effective January 1, 2027.
As of June 30, 2026, total medical customers numbered 18,413 thousand within 182,765 thousand total customer relationships. For full year 2026, the company now expects consolidated adjusted income from operations of at least $30.45 per share, with Evernorth and Cigna Healthcare projected to generate at least $6,900 million and $4,550 million of pre-tax adjusted income, respectively.
The Cigna Group reported initial equity holdings for officer Bryan Holgerson. He holds 6,957 shares of common stock directly and 735.9274 shares indirectly through The Cigna Group’s 401(k) Plan. In addition, he has 941.8085 phantom stock units, each economically equivalent to one common share but settled in cash under the Executive Deferred Compensation Plan. Holgerson also holds several employee stock option grants covering 10 separate blocks of common stock at exercise prices between $183.4405 and $336.4750, with vesting in three annual installments and expirations between 2028 and 2036.
Cigna Group officer Adam Kautzner filed an initial ownership report on Form 3. He holds 13,532.5100 shares of Cigna common stock directly. He also holds several employee stock options to buy Cigna common stock, with exercise prices between $183.4405 and $336.4750 and expirations from 2029 through 2036, vesting in three equal annual installments as described.
Cigna Group officer Jason D. Sadler filed an initial ownership report showing direct holdings of 34,705 shares of common stock. He also holds several employee stock options to acquire additional common shares at exercise prices between $287.5475 and $336.4750, with expirations from 2033 to 2036. Footnotes state these options vest in three equal annual installments beginning on March 1 of 2024, 2025, 2026, and 2027, as applicable.
Cigna Group reported the initial holdings of officer Sanford Paul A in its common stock. The report lists 4,073 shares of Common Stock, $.01 par value, held directly. No specific buy, sell, or derivative transactions are disclosed; the entry records existing ownership.
Cigna Group officer Matthew Perlberg reported his initial beneficial ownership of company equity. He directly holds 9,345 shares of common stock. He also holds several employee stock options to acquire additional common shares, with exercise prices between $227.0200 and $336.4750 and expiration dates ranging from 2032 to 2036. Footnotes state these options vest in three equal annual installments beginning on various March 1 dates from 2023 through 2027.
Cigna Group Chief Accounting Officer Jamie G. Kates exercised employee stock options for 899 shares of common stock at $152.8947 per share and, on the same date, sold 899 shares in an open-market transaction at $298.612 per share. Following these transactions, Kates directly holds 2,368 Cigna common shares. The exercised option was originally granted on February 28, 2018 and vested in three equal annual installments beginning February 28, 2019.